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DNA polymerase ν (POLN or pol ν) is a newly discovered A family polymerase that generates a high
error rate when incorporating nucleotides opposite dG; its translesion DNA synthesis (TLS) capability
has only been demonstrated for high ﬁdelity replication bypass of thymine glycol lesions. In the current
investigation, we describe a novel TLS substrate speciﬁcity of pol ν, demonstrating that it is able to
bypass exceptionally large DNA lesions whose linkages are through the DNA major groove. Speciﬁcally,
pol ν catalyzed efﬁcient and high ﬁdelity TLS past peptides linked to N6-dA via a reduced Schiff base
linkage with a γ-hydroxypropano-dA. Additionally, pol ν could bypass DNA interstrand cross-links with
linkage between N6-dAs in complementary DNA strands. However, the chemically identical DNA-peptide
and DNA interstrand cross-links completely blocked pol ν when they were located in the minor groove
via a N2-dG linkage. Furthermore, we showed that pol ν incorporated a nucleotide opposite the 1,N6-
etheno-dA (εdA) in an error-free manner and (+)-trans-anti-benzo[a]pyrene-7,8-dihydrodiol 9,10-epoxide-
dA [(+)-BPDE-dA] in an error-prone manner, albeit with a greatly reduced capability. Collectively,
these data suggest that although pol ν bypass capacity cannot be generalized to all major groove DNA
adducts, this polymerase could be involved in TLS when genomic replication is blocked by extremely
large major groove DNA lesions. In view of the recent observation that pol ν may have a role in cellular
tolerance to DNA cross-linking agents, our ﬁndings provide biochemical evidence for the potential
functioning of this polymerase in the bypass of some DNA-protein and DNA-DNA cross-links.
Introduction
Translesion DNA synthesis (TLS)
1 is a signiﬁcant DNA
damage tolerance mechanism to overcome replication blocks
caused by DNA lesions or to seal gaps opposite lesions (1, 2).
In the past decade, numerous DNA polymerases (pols) have
been discovered that possess lesion bypass activity. Recently,
a new human DNA pol has been identiﬁed, POLN or pol ν,
and falls in the A-family of DNA pols (3). This family includes
Escherichia coli (E. coli) pol I and human pol θ. Pol ν is a
moderately processive enzyme and is able to carry out strand
displacement DNA synthesis with much higher efﬁciency than
the Klenow fragment, the pol-proﬁcient portion of E. coli pol
I. It also replicates nondamaged (ND) DNA with low ﬁdelity;
speciﬁcally, it frequently misincorporates dT opposite template
dG with about half the efﬁciency of incorporation of the correct
nucleotide dC opposite template dG (4, 5). Because low ﬁdelity
of DNA synthesis is common for TLS pols and pol ν lacks
3′f5′ exonuclease proofreading activity, a role of pol ν in the
bypass of speciﬁc DNA lesions has been proposed (4, 5). Indeed,
this pol can carry out TLS in vitro, being speciﬁcally proﬁcient
in accurate bypass of thymine glycols, major groove DNA
lesions (5). However, it is completely blocked by a number of
other DNA modiﬁcations, including a cisplatin-induced GpG
intrastrand cross-link, an abasic site, a cyclobutane pyrimidine
dimer, and a thymine-thymine 6-4 photoproduct (5).
A function of pol ν in DNA cross-link repair in mammalian
cells has been proposed (6). In particular, the data suggested
that pol ν is involved in homologous recombination in response
to various DNA cross-linking agents and potentially interacts
with multiple proteins in the Fanconi anemia pathway, which
are relevant to DNA cross-link repair. However, a cellular role
for pol ν in homologous recombination-independent, TLS-
dependent repair of DNA cross-links has not yet been addressed.
Additionally, as already mentioned, thymine glycol is the only
lesion that pol ν has been reported to be able to bypass in vitro
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Published on Web 01/26/2010(5). To understand the cellular function of pol ν in TLS, it is
crucial to identify types of DNA lesions that this pol can bypass.
Because it has been previously established that both the exo+
and the exo- Klenow fragment can catalyze TLS past certain
major groove DNA adducts (7, 8), we hypothesized that in
addition to thymine glycols, pol ν may catalyze replication
bypass of additional major groove DNA lesions. This study was
designed to test this hypothesis to facilitate insight into the
cellular function of pol ν in TLS.
Experimental Procedures
Materials. [γ-32P]ATP was obtained from PerkinElmer Life
Sciences (Waltham, MA). P-6 Bio-Spin columns were obtained
from Bio-Rad (Hercules, CA). Uracil DNA glycosylase, T4 DNA
ligase, and T4 polynucleotide kinase were purchased from New
England BioLabs (Beverly, MA). Sodium cyanoborohydride was
obtained from Sigma (St. Louis, MO). Slide-A-Lyzer dialysis
cassettes with a molecular weight cutoff of 10000 were purchased
from Thermo Scientiﬁc (Rockford, IL). Human pol ν was puriﬁed
as described (5). Yeast pol δ and PCNA were puriﬁed as previously
described (9) and were generous gifts from Dr. Peter M. J. Burgers
(Washington University, St. Louis, MO). The Lys-Trp-Lys-Lys and
Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr peptides were
obtained from Sigma-Genosys (St. Louis, MO).
Oligodeoxynucleotide Synthesis. (a) All ND oligodeoxynucle-
otides were synthesized by the Molecular Microbiology and
Immunology Research Core Facility at Oregon Health & Science
University (Portland, OR).
(b) Oligodeoxynucleotides containing γ-hydroxypropano-dA or
γ-hydroxypropano-dG were synthesized as previously described
(10). DNAs containing DNA-peptide cross-links (PCLs) (Figure
1a,c) were prepared by the reaction of the γ-hydroxypropano-dA-
or γ-hydroxypropano-dG-containing oligodeoxynucleotides with
either 20 nmol of Lys-Trp-Lys-Lys or 4 nmol of Lys-Phe-His-Glu-
Lys-His-His-Ser-His-Arg-Gly-Tyr in the presence of 50 mM sodium
cyanoborohydride according to the previously published procedure
(11). The sequences of oligodeoxynucleotides containing a N6-dA
PCL and a N2-dG PCL are shown in Table 1, column 2, rows 1
and 2, respectively.
(c) The synthesis of the oligodeoxynucleotides containing inter-
strand DNA cross-link (ICL) between N6-dAs of complementary
strands (Figure 1b) is described in the Supporting Information. The
sequences of a N6-dA ICL1 and a N6-dA ICL2 are shown in Table
1, column 2, rows 3 and 5, respectively. The N6-dA ICL2
oligodeoxynucleotide was generated from a precursor oligodeoxy-
nucleotide (pre-N6-dA ICL2, Table 1, column 2, row 4) as described
previously (12).
(d) Oligodeoxynucleotides containing an ICL between N2-dGs
(Figure 1d) were synthesized as previously described (12-14), and
the sequences of the oligodeoxynucleotides containing each N2-
dG-N2-dG ICL (N2-dG ICL1, N2-dG ICL2, N2-dG ICL3, and N2-
dG ICL4) are shown in Table 1, column 2, rows 6-9. A detailed
description of each type of N2-dG ICLs has been reported previously
(12).
(e) An oligodeoxynucleotide containing 1,N6-etheno-dA (εdA)
(Figure 1e and Table 1, column 2, row 10) was synthesized by the
Molecular Microbiology and Immunology Research Core Facility
at Oregon Health & Science University (Portland, OR).
(f) An oligodeoxynucleotide (5′-CTCTCACTTCC-3′) containing
(+)-trans-anti-benzo[a]pyrene-7,8-dihydrodiol 9,10-epoxide-dA [(+)-
BPDE-dA] (Figure 1f) at the underlined nucleotide was synthesized
as previously described (15) and was a generous gift from Dr.
Nicholas E. Geacintov (New York University, NY). This oligode-
oxynucleotide was ligated to 16-mer oligodeoxynucleotide (5′-
ATTCCGTATCCATTTT-3′) using 800 units of T4 DNA ligase at
12 °C overnight in the presence of 23-mer scaffold oligodeoxy-
nucleotide (5′-TGGATACGGAATGGAAGTGAGAG-3′). The li-
gation reaction was terminated by the addition of an equal volume
of formamide dye solution [95% (v/v) formamide, 10 mM EDTA,
0.03% (w/v) xylene cyanol, and 0.03% (w/v) bromphenol blue],
and the products were separated on a 10% acrylamide gel containing
8 M urea. DNA was eluted from the gel with 0.5 M ammonium
acetate/10 mM magnesium acetate solution, dialyzed against 10
mM Tris-HCl (pH 7.4) buffer containing 1 mM EDTA in Slide-
A-Lyzer dialysis cassette (MWCO of 10000), and further puriﬁed
through a P-6 Bio-Spin column. The resulting 27-mer was used
for DNA replication assays (Table 1, column 2, row 11).
DNA Replication Assays. For replication assays, primers were
designed for reactions under a running or standing start condition.
In the former case, the primer 3′-OH was positioned several
nucleotides upstream of the lesion site. In latter case, the primer
3′-OH was positioned immediately prior to the lesion site (-1
primer). The sequences of primers are listed in Table 1, column 3.
DNA replication assays were carried out in the following buffers:
For pol ν, the reaction mixture contained 25 mM Tris-HCl (pH
7.5), 8 mM MgCl2, 10% glycerol, 100 µg/mL bovine serum
albumin, and 5 mM dithiothreitol. For reaction with pol ν with
N2-dG-N2-dG ICLs, Mg-acetate was used instead of MgCl2. For
pol δ, the reaction mixture contained 40 mM Hepes-KOH (pH 6.8),
10% glycerol, 200 µg/mL bovine serum albumin, 1 mM dithio-
threitol, and 8 mM MgCl2. All reactions were carried out at 37 °C.
DNA substrate, pol, and dNTP(s) concentrations, as well as reaction
times, are given in ﬁgure legends. Reaction products were resolved
through 15% acrylamide gel containing 8 M urea and visualized
using a PhosphorImager screen. The percentage of primer extended
in extension reactions was determined by taking the ratio of
extended primer beyond the adducted base to the total amount of
primer (unextended primer + extended primer up to and opposite
the lesion + extended primer beyond the lesion). The percentage
Figure 1. Structures of DNA adducts. The PCLs consist of either a
tetra (Lys-Trp-Lys-Lys) or dodecyl (Lys-Phe-His-Glu-Lys-His-His-Ser-
His-Arg-Gly-Tyr) peptide attached via an acrolein moiety at the N6
position of dA (a) or N2 position of dG (c). The resulting PCLs are
referred to as N6-dA PCL4, N6-dA PCL12, N2-dG PCL4, and N2-dG
PCL12. (b) Structure of N6-dA-N6-dA interstrand cross-link. (d)
Structure of N2-dG-N2-dG interstrand cross-link. (e) Structure of 1,N6-
etheno-dA. (f) Structure of (+)-trans-anti-BPDE-dA.
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mined by taking the ratio of extended primer to the total amount
of primer (unextended primer + extended primer). Quantiﬁcations
were done using ImageQuant 5.2 software.
Results
Replication Bypass of N6-dA Peptide Cross-Links by
Pol ν. To address the hypothesis that pol ν can catalyze
replication bypass of additional major groove DNA lesions, we
utilized N6-dA acrolein-mediated PCLs as a model for the bulky
major groove DNA adducts (11). Speciﬁcally, tetra- and
dodecylpeptide cross-links (Figure 1a, N6-dA PCL4 and N6-dA
PCL12, respectively) were used. The molecular masses of these
PCL-modiﬁed bases were 763 Da for N6-dA PCL4 and 1738
Da for N6-dA PCL12 versus 135 Da for unmodiﬁed adenine.
These lesions were positioned 15 nucleotides from the 5′ end
of the 30-mer template and annealed with a 16-mer radiolabeled
primer in which the 3′-OH was three nucleotides upstream of
the lesion site.
Data in Figure 2a revealed that pol ν could fully extend
primers annealed to these adducted templates; under the
conditions used, very minimal blockage to DNA synthesis was
observed one nucleotide prior to the lesion. To assess the identity
of the nucleotides incorporated opposite the lesion, single
nucleotide incorporations were conducted. Because N6-dA
PCL12 is bulkier than N6-dA PCL4, further assays used only
substrate containing this lesion. Data showed that pol ν
incorporated only the correct nucleotide, dT, opposite N6-dA
PCL12 (Figure 2b), suggesting that it catalyzed error-free bypass
of this adduct. It is of interest to note that two nucleotides were
incorporated for both the ND and the N6-dA PCL12 substrates
when only dTTP was present. It has been reported that pol ν
catalyzes error-prone insertion of dT opposite dG (4, 5). Because
the templating nucleotide immediately downstream of the
adducted base is a dG, this speciﬁc sequence context likely
accounts for the observed incorporation of the second dT. To
quantitatively evaluate the extent of the blockage posed by N6-
dA PCL12 for the pol ν-catalyzed nucleotide insertion, dTTP
titration assays (6.4 nM to 100 µM dTTP at 5-fold incrementally
increased concentrations, left to right) were performed (Figure
2c). These results demonstrated that pol ν could incorporate
approximately an equal amount of dT opposite the adducted
base at concentrations only 5-fold higher relative to ND dA;
speciﬁcally, ∼20% of primers were extended at 800 nM dTTP
using ND substrate and at 4 µM dTTP using damaged substrate.
Replication Bypass of N6-dA-N6-dA DNA Interstrand
Cross-Links by Pol ν. Having demonstrated that pol ν can
readily bypass N6-dA PCLs, we hypothesized that it may also
be able to carry out TLS past other N6-dA major groove adducts,
including N6-dA-N6-dA ICLs (Figure 1b). Although ICLs had
been previously thought to pose an insurmountable block to
replication, our laboratory has recently demonstrated that human
DNA pol κ and E. coli DNA pol IV can catalyze replication
bypass of an ICL between the N2-positions of dGs, which models
the ICL formed by acrolein in a CpG sequence context (12, 16).
Related ICLs were constructed between the N6-positions of dA
placing the cross-link in the major groove (Figure 1b and Table
1, rows 3 and 5). An N6-dA ICL1 was designed to model for a
potential intermediate of ICL processing that could be generated
by exo/endonucleolytic removal of DNA patch 3′ to the ICL
site. Even though N6-dA ICL1 contains an eight nucleotide
duplex region 5′ to the ICL site, it was anticipated that pol ν
would efﬁciently catalyze strand displacement DNA synthesis
due to its intrinsic high strand displacement activity (5), a
property that is useful for replicating this type of DNA lesion.
A N6-dA ICL2 was constructed to model another potential
intermediate of ICL processing; this could be generated by
removal of DNA patches both 3′ and 5′ to the ICL site. When
these major groove ICL-containing DNAs were used in primer
extension reactions, pol ν could extend primers and generate
full-length products (Figure 3a,b). For both types of ICLs, the
amount of primers extended beyond the adducted site was less
as compared to ND substrate; speciﬁcally, a 10- and 4-fold
decrease was observed for N6-dA-ICL1 and N6-dA-ICL2,
Table 1. Sequences of DNA Primers and Lesion-Containing Templates
a
a Modiﬁed bases are underlined. A 3′-glycerol unit (gl) or a dideoxycytidine (dd) were incorporated to prevent DNA synthesis off of the shorter
strand of the ICL-containing oligodeoxynucleotides. The number in the parentheses in front of the primer sequence indicates the position of the primer
3′-OH.
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synthesis on the N6-dA ICL1 template (Figure 3a). When the
identity of nucleotides incorporated opposite the cross-linked
site was examined by single nucleotide incorporations using the
N6-dA ICL2 template, the data indicated that pol ν preferentially
incorporated the correct nucleotide, dT, opposite the N6-modiﬁed
dA (Figure 3c).
Pol ν-Catalyzed Replication Is Blocked by N2-dG
Peptide and DNA Interstrand Cross-Links. Given that pol ν
was able to bypass the extremely bulky major groove N6-dA
PCLs and ICLs, we tested whether it could replicate past
chemically identical PCL and ICL lesions except situated in
the minor groove through a linkage with the N2 position of dG
(Figure 1c,d). Primer extensions using these N2-dG linked PCLs
revealed that pol ν was strongly blocked one nucleotide prior
to both PCLs and was completely blocked at the site opposite
the lesion, with no further primer extension observed (Figure
4a). The identity of the nucleotide(s) incorporated opposite the
PCLs was not determined due to the limited nucleotide
incorporation. Even though pol ν could not replicate past the
N2-dG PCLs, suggesting an inability to replicate past minor
groove DNA adducts, we tested whether pol ν could catalyze
TLS past N2-dG-N2-dG ICLs (Figure 1d and Table 1, rows
6-9). No incorporation opposite the lesion site was observed
for these ICL-containing DNAs (Figure 4b). Thus, similar to
the observations made using PCL-containing DNAs, pol ν has
much higher tolerance for the major groove N6-dA ICLs than
the minor groove N2-dG ICLs.
Substrate Limitations of Pol ν-Catalyzed Bypass of
Major Groove-Linked DNA Lesions. Because pol ν was able
to accurately replicate past major groove N6-dA PCL and ICL
lesions, we wanted to further explore the substrate range of pol
ν and address the question concerning pol ν ability to bypass
dA adducts in which both N1 and N6 sites are blocked by
modiﬁcation. Thus, the ability of pol ν to bypass an εdA (Figure
1e) was examined. εdA is a promutagenic lesion that can be
formed by exposure to industrial toxicants such as vinyl chloride
and by the reaction of DNA with bis-electrophiles produced by
lipid peroxidation (17). The running start primer extensions
demonstrated that pol ν was severely blocked one nucleotide
prior to the εdA adduct, with only a very small amount of full-
length product formed (Figure 5a). However, the nucleotide
incorporation opposite the lesion appeared to be quite accurate.
Under the conditions used, the primers were extended in the
presence of dTTP but not other dNTPs (Figure 5b). On the basis
of these data, we conclude that relatively nonbulky modiﬁcations
at both N1 and N6 of dA are sufﬁcient to inhibit pol ν-catalyzed
TLS.
We also investigated the ability of pol ν to carry out TLS
past (+)-BPDE-dA (Figure 1f), one of the adducts formed by
the active metabolite of the prevalent environmental pollutant,
benzo[a]pyrene (18). To construct an oligodeoxynucleotide of
sufﬁcient length for TLS analyses, an 11-mer oligodeoxynucle-
otide containing the (+)-BPDE-dA was 32P-labeled, ligated to
Figure 2. Replication bypass of N6-dA peptide cross-links by human
pol ν. (a) Primer extensions were catalyzed by 50 nM human pol ν
under running start conditions (-3 primer) in the presence of 5 nM
primer template containing ND, N6-dA PCL4, or N6-dA PCL12 for 30
min at 37 °C. (b) Single nucleotide incorporations and primer extensions
were catalyzed by 5 nM human pol ν under standing start conditions
(-1 primer) in the presence of 2 nM primer template containing ND
or N6-dA PCL12 for 15 min at 37 °C. Reactions shown in lanes 1-6
and lanes 7-12 were conducted side-by-side, and products were
separated on the same gel. The reactions shown in panels a and b were
carried out in the presence of 100 µM individual or all dNTPs. (c)
dTTP titration assays with 2 nM primer template were catalyzed by 5
nM human pol ν under standing start conditions (-1 primer) for 10
min at 37 °C using the same substrates as described in panel b. dTTP
concentration ranges from 6.4 nM to 100 µM (5-fold incremental
increase). Reactions shown in lanes 1-8 and lanes 9-16 were
conducted side-by-side, and products were separated on the same gel.
Figure 3. Replication bypass of N6-dA-N6-dA interstrand cross-links
by human pol ν. Primer extensions were catalyzed by 10 nM human
pol ν under running start conditions (-9 primer) using ND, N6-dA ICL1
(a), or N6-dA ICL2 (b). Reactions shown in lanes 1-2 and lanes 3-4
were conducted side-by-side, and products were separated on the same
gel. (c) Single nucleotide incorporations and primer extensions were
catalyzed by 5 nM human pol ν under standing start conditions (-1
primer) using ND and N6-dA ICL2. All reactions were carried out in
the presence of 5 nM primer template and 100 µM individual or all
dNTPs for 15 min at 37 °C.
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radioactive signals of the resulting 27-mer template are evident
in all lanes [Figure 5c,d, (+)-BPDE-dA-27-mer template].
Primer extensions revealed that pol ν could not fully extend
the -6 primer and was severely blocked one nucleotide prior
to the adducted site (Figure 5c). In addition, pol ν displayed
error-prone patterns of nucleotide incorporation opposite the
lesion (Figure 5d); in the presence of dATP, ∼16% of primers
were extended, while only ∼1% of primers were extended in
the presence of the correct dTTP. A limited primer extension
(<1%) was also observed in the presence of dGTP. Overall,
pol ν-catalyzed TLS past (+)-BPDE-dA was inefﬁcient, in-
complete, and error-prone.
Discussion
Although very signiﬁcant progress has been made in both
structural analyses of many of the TLS pols and the range of
damaged DNA substrates that these pols can bypass, in the
majority of cases, the biological role of these enzymes can only
be inferred by changes in efﬁciency and mutagenic rates of TLS
in their absence. Little data have been gathered concerning the
role of these enzymes in developmental biology, their tissue-
speciﬁc expression and steady-state distribution in adult organ-
isms, the mechanism(s) for recruitment to sites of DNA damage,
and the processes that regulate their expressions in response to
environmental toxicant exposures and/or endogenous stresses.
In the case of pol ν, the initial characterizations have demon-
strated a very limited repertoire of lesions that pol ν can
efﬁciently bypass (5). Although a cellular role of pol ν in TLS
has not yet been established, its high frequency of misincor-
poration of dT opposite dG suggests that its expression would
be tightly regulated. Thus, understanding the potential substrate
speciﬁcity of pol ν may help to guide future investigations of
its biological role in TLS and circumstances for induction or
activation. In this regard, we demonstrated that although pol ν
could carry out TLS past bulky major groove DNA lesions such
as N6-dA PCLs and N6-dA-N6-dA ICLs, it failed to replicate
DNAs containing chemically similar minor groove DNA lesions.
Thus, the location of the lesion within DNA is one important
structural determinant that inﬂuences the ability of pol ν to
bypass the lesion.
We also discovered that pol ν could not efﬁciently bypass
εdA, and we speculate that this may be either due to pol ν
requirement for the Watson-Crick edge for efﬁcient dA
templating or structural heterogeneity of the lesion within the
active site. Regarding the former possibility, pol ν may fail to
catalyze efﬁcient TLS past εdA because the Watson-Crick edge
of this adduct is blocked by the modiﬁcation. The majority of
DNA pols utilize the geometry of the canonical Watson-Crick
pairs for the nucleotide selection (19), but some TLS pols utilize
alternative mechanisms. For example, pol ι induces a syn
conformation on template purines, which results in a Hoogsteen
base pairing with the correctly matched incoming nucleotide
and enables bypass of lesions that disrupt the Watson-Crick
edge but not the Hoogsteen edge (20). The diminished capability
of pol ν to bypass εdA strongly suggests that the accessibility
of the Watson-Crick edge of the template dA is important for
the efﬁcient replication by this pol; thus, it is likely that pol
ν-catalyzed polymerization involves the recognition of the
Watson-Crick geometry.
With regard to structural heterogeneity of εdA adduct, NMR
analyses have revealed that orientation of the base around the
glycosydic bond is affected by identity of nucleotide opposite
the lesion (21, 22). When paired with dT, the εdA is in a normal
anti conformation; however, the εdA base prefers the syn
conformation when placed opposite a mispaired dG. Addition-
ally, the cocrystal structure of DNA containing an εdA bound
to pol ι also revealed that the lesion adopted a syn conformation
(20). Thus, εdA can adopt a syn or anti conformation depending
on the base it is paired with, as well as interactions with the
pol. There is a possibility that similar to pot ι, the adducted
base is in a syn conformation in the pol ν active site. However,
it is unclear whether either orientation of the ε-modiﬁed base
can be efﬁciently utilized for nucleotide insertion.
Intriguingly, pol ν also could not fully bypass a (+)-BPDE-
dA. The NMR solution structure of this lesion opposite dT in
duplex DNA showed complex conformational heterogeneity
(23). Computational studies using an NMR structure of duplex
DNA where dT was placed opposite the modiﬁed dA have
revealed that the glycosydic bond of (+)-BPDE-dA was in syn-
anti equilibrium; therefore, the modiﬁed dA has a diminished
capability to participate in Watson-Crick base pairing (24). It
is possible that the glycosydic bond of modiﬁed dA rotates and
adopts a syn conformation at the primer-template junction and
therefore cannot participate in Watson-Crick base pairing. An
alternative explanation may be that the structure of the active
site of pol ν is signiﬁcantly distorted by bulky aromatic ring
system of this lesion. It has been shown that the BPDE moiety
of this lesion is intercalated into the double helix, on the 3′
side of the adducted dA, and thus causes signiﬁcant structural
distortions at the active site of T7 pol (25). Because the T7 pol
is also a member of the A-family pols, the inability of pol ν to
Figure 4. Replication bypass of N2-dG peptide and interstrand cross-
links by human pol ν. (a) Primer extensions were catalyzed by 10 nM
human pol ν under running start conditions (-4 primer) in the presence
of 5 nM primer template containing ND, N2-dG PCL4, or N2-dG PCL12
for 30 min at 37 °C. (b) Primer extensions were catalyzed by 25 nM
human pol ν under running start conditions (-10 primer) in the presence
of 7.5 nM primer template containing ND, N2-dG ICL1, N2-dG ICL2,
N2-dG ICL3, or N2-dG ICL4 for 10 min at 37 °C. All reactions were
carried out in the presence of 100 µM dNTPs.
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similar to those shown for T7 pol. With regard to the low ﬁdelity
synthesis past this lesion by pol ν, it has been shown that the
adducted dA is displaced from the active site of T7 pol as a
result of steric hindrance between the BPDE moiety and the
primer template. Among the four dNTPs, dATP ﬁts best into
the dNTP binding pocket that is enlarged due to the displace-
ment of adducted dA (25). This structural change provides a
likely explanation for the predominant misincorporation of dA
by pol ν.
Recently, we reported a comparative study of the mutagenic
consequences of identical lesions linked in the major groove
via N6-dA versus the minor groove linkage via N2-dG during
the replication of single-stranded pMS2 shuttle vectors in COS-7
cells (11); these lesions were the same site-speciﬁc PCL4s
substrates used in this investigation. These data revealed that
DNA containing either lesion could be replicated, with the N2-
dG PCL4 being moderately mutagenic, while the N6-dA PCL4
showed very low mutagenic potential. Although it is anticipated
that the extremely bulky nature of the N6-dA PCLs lesions would
Figure 5. Replication bypass of 1,N6-etheno-dA and (+)-trans-anti-BPDE-dA by human pol ν. (a) Primer extensions were catalyzed by 10 nM
human pol ν under running start conditions (-3 primer) in the presence of 5 nM primer template containing ND or εdA. (b) Single nucleotide
incorporations and primer extensions were catalyzed by 5 nM human pol ν under standing start conditions (-1 primer) in the presence of 5 nM
primer template using the same substrates as described in panel a. (c) Primer extensions were catalyzed by 10 nM human pol ν under running start
conditions (-6 primer) in the presence of 2 nM primer template containing ND or (+)-BPDE-dA. (d) Single nucleotide incorporations and primer
extensions were catalyzed by 5 nM human pol ν under standing start conditions (-1 primer) in the presence of 2 nM primer template using the
same substrates as described in panel c. All reactions were carried out in the presence of 100 µM individual or all dNTPs for 15 min at 37 °C.
Figure 6. Replication bypass of N6-dA peptide cross-link by yeast pol δ. (a) Single nucleotide incorporations and primer extensions were catalyzed
by 0.5 nM yeast pol δ with 2 nM primer template containing ND or N6-dA PCL12 under standing start conditions (-1 primer) in the presence or
absence of 5 nM PCNA for 20 min at 37 °C. Reactions were carried out in the presence of 100 µM individual or all dNTPs. (b) dTTP titration
assays with 2 nM primer template were catalyzed by 0.5 nM yeast pol δ under standing start conditions (-1 primer) in the absence of PCNA for
10 min at 37 °C using the same substrates as described in panel a. dTTP concentration ranges from 6.4 nM to 100 µM (5-fold incremental increase).
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using pol δ (Figure 6). The primer extensions and single
nucleotide incorporations showed some limited bypass of N6-
dA PCL12 at very high dNTP concentrations (100 µM) (Figure
6a), while the titration experiment with varying concentrations
of dTTP (from 6.4 nM to 100 µM) revealed the severity of the
blockage posed by this lesion for the pol δ-catalyzed nucleotide
insertion (Figure 6b). Speciﬁcally, pol δ could incorporate dT
opposite the ND dA at concentrations as low as 6.4 nM with
∼8% of primers being extended, while even at 100 µM dTTP,
only ∼2% of primers were extended on the N6-dA PCL12-
containing substrate. These results suggest that although in vitro
conditions could be manipulated to observe bypass of N6-dA
PCLs by pol δ, the block to replication is likely to occur when
pol δ encounters such bulky lesions; therefore, specialized pols
may be recruited to carry out TLS. The data presented herein
suggest that pol ν is a likely candidate to perform TLS past a
variety of major groove lesions. At present, the structural basis
is unknown why pol ν could efﬁciently bypass PCL and ICL
as large as 3025 Da but fails to bypass less bulky BPDE adduct.
However, we speculate that the lesions that are readily bypassed
by pol ν may have signiﬁcant conformational ﬂexibility and
thus, can be accommodated without distorting DNA-enzyme
interactions within the pol active site. Overall, our data suggest
that since pol ν is capable of bypassing extremely large major
(but not minor) groove lesions, it may play a role in TLS
following toxicant challenges that result in the formation of such
lesions in the cells.
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